Sign in
4

Changes in Ownership

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001048477-24-000114

EVP, Chief Financial Officer sold 5,000 shares at $75.19 ($375,950)

  • EVP, Chief Financial Officer acquired 5,000 shares (option exercise)
  • EVP, Chief Financial Officer acquired 300 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Mueller Brian · EVP, Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-30 Grant or award : show line 1 in the form 10b5-1 +300 $68.65 $20,594 72,159 D
2024-05-30 Exercise or conversion : show line 2 in the form 10b5-1 +5,000 $63.10 $315,500 77,159 D
2024-05-30 Sale : show line 3 in the form 10b5-1 −5,000 $75.19 $375,950 72,159 D
Open-market sales · 5,000 sh · avg $75.19 · $375,950

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-30 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy Common Stock) −5,000 0 D
Loading xslF345X05/wk-form4_1717194476.xml…